The 13th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD) will bring together the entire community involved in viral hepatitis research, to promote better understanding of the viruses that cause hepatitis in humans, as well as pathogenesis, natural history, complications, treatment, and prevention of the diseases they cause.
The 13th ISVHLD continues the tradition of the recent landmark meetings held in Paris, Sydney, Atlanta, Rome, and Tokyo, it will commemorate progress made in the global fight against viral hepatitis and liver disease and focus the field's attention on the key future challenges.
Register
For more information visit the ISVHLD 2009 website or see below for program details.
Preliminary Program
Day 1: Friday, March 20, 2009
Noon–6:00 pm Registration
1:00-3:00 pm Satellite Symposium #1 (TBD)
3:30-5:30 pm Satellite Symposium #2 (TBD)
6:00-8:00 pm Plenary Session 1. Welcome & Introductory
6:00-6:15 pm Welcome to the Meeting Jay Hoofnagle & David Thomas
6:15-6:30 pm Welcome to Washington, DC. TBA
6:30-7:00 pm The Global Burden of Viral Vepatitis. Miriam Alter
7:00-7:30 pm The Natural History of Hepatitis C. Harvey Alter
7:30-8:00 pm Micro RNAs and Pathogenesis of Viral Illness. Bryan Cullen
8:00 pm Cocktail Reception in Poster Area
Day 2, Saturday March 21, 2009
6:30-8:00 am Breakfast with the Professor/Investigator (5-10)
8:30-10:05 am Plenary Session 2: HAV & HEV
8:30 am Hepatitis A Virus: Stan Lemon
9:00 am Hepatitis E Virus: Robert Purcell
9:30 am Hepatitis E as a Zoonosis: X-J Meng
9:50 am Plenary Abstract #1
10:05-10:30 am Break
10:30-11:45 am Plenary Session 3: Global Control of Viral Hepatitis10:30 HAV Vaccination and Control of HAV infection: Daniel Shouval
10:50 am HEV Vaccination, Current Status: Bruce Innis
11:10 am HBV vaccination and Control of HBV Infection: DS Chen
11:30 am Plenary Abstract #2
Noon-3:00 pm Poster Viewing and Review
12:15-1:15 pm Satellite Luncheons
3:00-5:00 pm Parallel Session 1. HAV, HEV and Global Control: 3:00-5:00
Six parallel sessions [with opening overview by moderator and 6 abstract presentations: 15 min each]
Parallel Session 1.1 HAV Virology. Gerardo Kaplan
Parallel Session 1.2 HEV Virology. Sue Emerson & Shunji Mishiro
Parallel Session 1.3 HEV & HAV Pathogenesis and Diagnostics. Kris Krawczynski & David Anderson
Parallel Session 1.4 HAV & HEV Control & Epidemiology. Pierre Van Damme
Parallel Session 1.5 Fulminant Viral hepatitis. Will Lee & Patricia Farci
6:00-8:00 pm Satellite Symposium #3
Day 3, Sunday March 22, 2009
6:30-8:00 am Breakfast with the Professor/Investigator (5-10)
8:30-10:15 am Plenary Session 4: HBV & HDV, Basic Virology & Immunology8:30 Hepatitis B virus, virology. William Mason
9:00 am Hepatitis D Virus, Virology. John Taylor
9:20 am Hepatitis B Pathogenesis. Stefan Weiland
9:40 am Natural History & Therapy of Hepatitis D. Mario Rizzetto
10:00 am Plenary Abstract #3
10:15 am Break
10:45 am-12:05 pm Plenary Session 5: HBV & HDV, Clinical Features & Outcome
10:45 am Natural History of Hepatitis B: Jenny Heathcote
11:05 am HBV/HIV Co-infection: Yves Benhamou
11:25 am Therapy of Hepatitis B: Anna Lok
11:45 am Antiviral Resistance in Chronic Hepatitis B. Stephen Locarnini
12:05-1:05 pm Lunch and Poster Viewing12:15-1:15 pm Satellite Luncheon Sessions (~4)
1:30-3:00 pm Parallel Session 2. 1:30-3:00 pm HBV and HDV-1.[Moderator overview & 5 abstracts]
Parallel Session 2.1 HBV Virology. Hans Will
Parallel Session 2.2 HDV Virology. Jeff Glenn
Parallel Session 2.3 HBV Markers and Progression. C-J Chen
Parallel Session 2.4 Therapy of Hepatitis B. Robert Perrillo
Parallel Session 2.5 HBV Epidemiology. Cindy Weinbaum
Parallel Session 2.6 HBV/HIV Coinfection. Chloe Thio
Parallel Session 2.7 HBV Pathogenesis. Allison Jilbert
3:00 pm Break
3:30-5:00 pm Parallel Session 3. 3:30-5:00 pm HBV and HDV-2.
[Moderator overview & 5 abstracts]
Parallel Session 3.1 HBV Virology. Ulrike Protzer
Parallel Session 3.2 HBV Vaccine & Prevention. Blaine Hollinger
Parallel Session 3.3 Interferon for Hepatitis B. Harry Janssen
Parallel Session 3.4 Immunology of HBV. Antonio Bertoletti
Parallel Session 3.5 Antiviral Resistance in HBV. Fabien Zoulim
Parallel Session 3.6 New Drugs for HBV. Stephan Urban
Parallel Session 3.7 Natural History of Hepatitis B. Y-L Liaw
Day 4, Monday March 23, 2009
6:30-8:00 am Breakfast with the Professor/Investigator (5-10)
8:30-10:00 am Plenary Session 6: HCV, Virology and Immunology
8:30 am Hepatitis C Virus, Virology: Charles Rice
9:00 am Hepatitis C Virus and the Innate Immune System: Michael Gale
9:20 am Hepatitis C virus and the Adaptive Immune Response: Barbara Rehermann
9:40 am Hepatitis C Vaccine: T. Jake Liang
10:00 am Break
10:30-11:55 am Plenary Session 7: HCV, Clinical Course and Treatment
10:30 am Therapy of Hepatitis C, Current: J-M Pawlotsky
10:50 am Therapy of Hepatitis C, Future: John McHutchison
11:20 am HCV/HIV Co-infection: David Thomas
11:40 am Plenary Abstract #4
Noon-1:30 pm Lunch and Poster Viewing
12:15-1:15 pm Satellite Luncheon Sessions (~4)
1:30-3:00 pm Parallel Session 4: HCV (1): 1:30-3:00 pm
[Moderator overview & 5 abstracts]
Parallel Session 4.1 HCV Virology. Darius Moradpour
Parallel Session 4.2 HCV Viral Kinetics. Alan Perelson
Parallel Session 4.3 Natural History of Fibrosis in HCV. R Fontana
Parallel Session 4.4 Current Therapies for HCV. Peter Ferenci
Parallel Session 4.5 New Agents for HCV. Ray Chung
Parallel Session 4.6 HCV Immunology & vaccines. Jane McKeating
Parallel Session 4.7 HCV Epidemiology. Joseph Perz
3:00 pm Break
3:30-5:00 pm Parrallel Session 5. HCV (2): 3:30-5:00 pm
[Moderator overview & 5 abstracts]
Parallel Session 5.1 HCV In Vitro Systems. Ralf Bartenschlager
Parallel Session 5.2 HCV Immunology. Chris Walker
Parallel Session 5.3 Acute HCV Infection. Michael Manns
Parallel Session 5.4 New Therapies for HCV. Geoffrey Dusheiko
Parallel Session 5.5 Liver Transplantation & HCV. Xavier Forns
Parallel Session 5.6 HCV/HIV Coinfection. Ken Sherman
Parallel Session 5.7 Control of HCV. Greg Dore
6:00-8:00 pm Satellite Symposium #4
Day 5, Tuesday March 24, 2009
8:00-9:45 am Plenary Session 8: Hepatocellular Carcinoma (HCC)
8:00 am Worldwide Epidemiology of HCC: Adrian Di Bisceglie
8:20 am Viral Carcinogenesis: Snorri Thorgiersson
8:40 am Management of HCC: Masao Omata
9:00 am Therapy of HCC: Jorge Bruix
9:30 am Plenary Abstract #5
9:45 am Break
10:00-11:30 am Parallel Session 6. HCC (1): 10:00-11:30 am Six Parallel Sessions
Parallel Session 6.1 Non-invasive Markers of HCC. Jorge Marreno
Parallel Session 6.2 Epidemiology of HCC. Hashem El-Serag
Parallel Session 6.3 Therapy of HCC. Josep Llovet
Parallel Session 6.4 Liver Transplantation for HCC. Richard Freeman
Parallel Session 6.5 Liver Carcinogenesis. TBA
11:45 am-12:45 pm Plenary Session 9. Future Directions
11:45 am-12:15 pm Molecular Pathogenesis of Chronic Viral Hepatitis: TBA
12:15-12:30 pm New Directions in Viral Hepatitis: Jay Hoofnagle
12:30-12:45 pm Future ISVHLD Meetings: 2012 Organizers
12:45 pm Adjourn